Health & Environmental Research Online (HERO)


Print Feedback Export to File
7418846 
Journal Article 
Hyperandrogenism in PCOS 
Georgopoulos, NA; Kandaraki, E; Panidis, D; , 
2009 
Springer US 
Boston, MA 
Diagnosis and Management of Polycystic Ovary Syndrome 
105-110 
In women with polycystic ovary syndrome (PCOS), hyperandrogenism is clinically manifested by hirsutism, acne and androgenic alopecia, and it contributes to chronic anovulation and menstrual dysfunction. Biochemically, hyperandrogenism is established by elevated circulating levels of serum total or unbound testosterone, androstenedione and an increased free androgen index (FAI). In prospective studies, hyperandrogenism appears to affect about 1 in 10 women of reproductive age [1], although racial differences or the selection criteria of patients can increase its prevalence up to 30% [2].